Evidence map›Paper›PMID 22689929›Full record

ArticleCirculation2012

Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines.

Daniel C Desimone, Imad M Tleyjeh, Daniel D Correa de Sa, Nandan S Anavekar, Brian D Lahr, Muhammad R Sohail, James M Steckelberg, Walter R Wilson, Larry M Baddour, Mayo Cardiovascular Infections Study Group

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 4 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 4 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Arquivos brasileiros de cardiologia · 2017
    Guideline
  3. Guideline
  4. Guideline
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Pediatric Infective Endocarditis: A Literature Review.Journal of clinical medicine · 2022
    Review
  12. Article
  13. Article
  14. Infective endocarditis and oral health-a Narrative Review.Cardiovascular diagnosis and therapy · 2021
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Daniel C DesimoneDepartment of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. desimone.daniel@mayo.edu
Imad M Tleyjeh
Daniel D Correa de Sa
Nandan S Anavekar
Brian D Lahr
Muhammad R Sohail
James M Steckelberg
Walter R Wilson
Larry M Baddour
Mayo Cardiovascular Infections Study Group
University of Vermont Medical Center · USUniversity of Vermont · USKing Fahd Medical City · SAMayo Clinic in Arizona · USWinnMed · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
NIA NIH HHS AG034676NIA NIH HHS R01 AG034676
6 · The paper itself

Abstract

backgroundThe American Heart Association published updated guidelines for infective endocarditis (IE) prevention in 2007 that markedly restricted the use of antibiotic prophylaxis in certain at-risk patients undergoing dental and other invasive procedures. The incidence of IE caused by viridans group streptococci (VGS) in the United States after publication of the 2007 American Heart Association guidelines has not been reported. METHODS AND

resultsWe performed a population-based review of all definite or possible cases of VGS-IE using the Rochester Epidemiology Project of Olmsted County, Minnesota. Patient demographics and microbiological data were collected for all VGS-IE cases diagnosed from January 1, 1999, through December 31, 2010. We also examined the Nationwide Inpatient Sample hospital discharge database to determine the number of VGS-IE cases included between 1999 and 2009. We identified 22 cases with VGS-IE in Olmsted County over the 12-year study period. Rates of incidence (per 100 000 person-years) during time intervals of 1999-2002, 2003-2006, and 2007-2010 were 3.19 (95% confidence interval, 1.20-5.17), 2.48 (95% confidence interval, 0.85-4.10), and 0.77 (95% confidence interval, 0.00-1.64), respectively (P=0.061 from Poisson regression). The number of hospital discharges with a VGS-IE diagnosis in the Nationwide Inpatient Sample database during 1999-2002, 2003-2006, and 2007-2009 ranged between 15 318 to 15 938, 16 214 to 17 433, and 14 728 to 15 479, respectively.

conclusionsOn the basis of data complete through 2010, there has been no perceivable increase in the incidence of VGS-IE in Olmsted County, Minnesota, since the publication of the 2007 American Heart Association endocarditis prevention guidelines.

Indexed as

American Heart AssociationViridans StreptococciEndocarditisEndocarditis, BacterialFemaleHumansIncidenceMalePopulation SurveillancePractice Guidelines as TopicStreptococcal InfectionsUnited States

Identifiers

PMID22689929
PMCPMC3681201
OpenAlexW2039596027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.